Programme
9.00 - 9.45 : Roles and Risks of Continuous Insulin Pump therapy in Type 1 Diabetes.
Professor Stephanie Amiel, Professor of Diabetic Medicine, Kings College, London.
9.45 - 10.30 : Impact of Oestrogen therapy on diabetes and vascular risk.
Dr Helen Buckler, Consultant Endocrinologist, Hope Hospital, Salford.
10.30 - 11.00 : Tea and Coffee
11.00 - 12.30 : The ABCD Debate: HbA1c is not a sufficiently reliable marker of glycaemic control in diabetes care.
Chaired by Dr Anne Kilvert, Consultant Physician, Northampton General Hospital.
Proposer: Dr William Jeffcoate, Consultant Diabetologist, City Hospital, Nottingham.
Opposer: Professor Sally Marshall, Professor of Diabetes, University of Newcastle upon Tyne.
12.30 - 13.30 : Lunch
13.30 - 13.50 : Antiplatelet effects of Rosiglitazone - A direct consequence of platelet PPAR gamma activation.
Dr Manish Khanolkar, Llandough Hospital, Winner of the ABCD SpR Training Award 2004.
13.50 - 14.15 : ABCD survey of services for gestational diabetes -
Dr Fahmy Hanna, University Hospital of North Staffordshire.
14.15 - 15.00 : Tariffs for specialist diabetes services – The final nail in the coffin?
Professor Anthony Barnett, Professor of Medicine, University of Birmingham.
15.00 - 15.45 : Hot topic: Findings and implications of the PROACTIVE study.
Professor John Betteridge, Professor of Diabetes & Endocrinology, The Middlesex Hospital
15.45 - 16.00 : Tea & coffee
16.00 - 16.45 : Anti-psychotic drugs and diabetes - genuine concern or industry hype?
Dr Richard Holt, Senior Lecturer, University of Southampton.
16.45 - 17.30 : Links between oxidative stress, inflammation and diabetic vascular disease.
Professor Naveed Sattar, Consultant Clinical Biochemist, Glasgow Royal Infirmary.
